Agilent Technologies Stock Today
| A Stock | USD 119.02 1.94 1.66% |
PerformanceVery Weak
| Odds Of DistressLow
|
Agilent Technologies is trading at 119.02 as of the 17th of June 2025, a 1.66 percent increase since the beginning of the trading day. The stock's open price was 117.08. Agilent Technologies has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Note, on June 2, 2025, Representative Rob Bresnahan of US Congress acquired under $15k worth of Agilent Technologies's common stock.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 18th of November 1999 | Category Healthcare | Classification Health Care |
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California. Agilent Technologies operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. The company has 284.06 M outstanding shares of which 4.14 M shares are presently sold short by investors with about 1.83 days to cover all short positions. More on Agilent Technologies
Moving together with Agilent Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Agilent Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO | Michael McMullen | ||||
| Thematic Ideas | (View all Themes) | ||||
| Old Names | [Armor Minerals Inc, Agilent Technologies Inc.] | ||||
| Business Concentration | Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, Stock Exchange Of, SP 500 Index, SRI Sustainable Growth, Measuring and Control Equipment, Healthcare, Health Care, Life Sciences Tools & Services, Diagnostics & Research, Healthcare (View all Sectors) | ||||
| Excise Tax Activities | Animal TestingCatholic | ||||
| Average Analyst Recommendation | |||||
Debt LevelsAgilent Technologies can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Agilent Technologies' financial leverage. It provides some insight into what part of Agilent Technologies' total assets is financed by creditors.
| |||||
Agilent Technologies (A) is traded on New York Stock Exchange in USA. It is located in 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 and employs 18,000 people. Agilent Technologies is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current capitalization of 33.26 B. Agilent Technologies operates under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 284.06 M outstanding shares of which 4.14 M shares are presently sold short by investors with about 1.83 days to cover all short positions.
Agilent Technologies has accumulated about 1.05 B in cash with 1.75 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.57.
Check Agilent Technologies Probability Of Bankruptcy
Ownership AllocationAgilent Technologies holds a total of 284.06 Million outstanding shares. The majority of Agilent Technologies outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Agilent Technologies to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Agilent Technologies. Please pay attention to any change in the institutional holdings of Agilent Technologies as this could imply that something significant has changed or is about to change at the company. On June 2, 2025, Representative Rob Bresnahan of US Congress acquired under $15k worth of Agilent Technologies's common stock.
Check Agilent Ownership Details
Agilent Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Findlay Park Partners Llp | 2025-03-31 | 1.3 M |
Agilent Technologies Historical Income Statement
Agilent Stock Against Markets
Agilent Technologies Corporate Directors
| Daniel Podolsky | Independent Director | Profile | |
| Hans Bishop | Independent Director | Profile | |
| George Scangos | Independent Director | Profile | |
| Sue Rataj | Independent Director | Profile |
Already Invested in Agilent Technologies?
The danger of trading Agilent Technologies is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Agilent Technologies is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Agilent Technologies. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Agilent Technologies is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agilent Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Agilent Stock refer to our How to Trade Agilent Stock guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilent Technologies. If investors know Agilent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilent Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.29) | Dividend Share 0.968 | Earnings Share 4.06 | Revenue Per Share | Quarterly Revenue Growth 0.06 |
The market value of Agilent Technologies is measured differently than its book value, which is the value of Agilent that is recorded on the company's balance sheet. Investors also form their own opinion of Agilent Technologies' value that differs from its market value or its book value, called intrinsic value, which is Agilent Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilent Technologies' market value can be influenced by many factors that don't directly affect Agilent Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilent Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilent Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilent Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.